Scroll Top

Services

CENTRUM HTA PROVIDES CONSULTANCY SERVICES CONCERNING PHARMACEUTICAL MARKET  IN POLAND

THE COMPANY’S ACTIVITY COVERS A WIDE RANGE OF CONSULTANCY SERVICES CONCERNING, IN PARTICULAR: PRODUCTION OF HEALTH TECHNOLOGY ANALYSES FOR PHARMACEUTICALS AND MEDICAL PRODUCTS.

FULL HTA DOSSIER

  • Decision Problem Analysis
  • Clinical analysis
  • Economic analysis
  • Budget Impact Analysis

CHARACTERISTICS OF THE PHARMACEUTICAL MARKET IN POLAND

REVIEW OF EPIDEMIOLOGICAL AND COST SPECIFIC DATA IN THE POLISH SETTINGS

SYSTEMATIC REVIEW OF CLINICAL TRIALS

BUDGET IMPACT ANALYSIS FOR GENERIC DRUGS

FULL TEXT PUBLICATIONS

WORKSHOPS
ON EBM AND HTA

ADVISORY BOARD

SCIENTIFIC CONFERENCES MATERIALS

FULL RANGE REIMBURSEMENT CONSULTING

HTA ANALYSES ARE CARRIED OUT BY CENTRUM HTA WITH GREAT ACCURACY, FULLY COMPLYING WITH THE CURRENT FORMAL REQUIREMENTS IN POLAND

  • Act of May 12, 2011 on reimbursement of medicines, foodstuffs for particular nutritional purposes and medical devices (as amended)
  • Ordinance of the Minister of Health of 24 September 2023 on the minimum requirements to be met by the analyses included in applications for reimbursement and on the fixing of the official retail price and the increase in the official retail price of medicinal products, special food supplements and medical devices which do not have a reimbursed counterpart for a given indication.
  • Health Technology Assessment Guidelines Version 3.0 Warsaw, August 2016 (publication date 14 of September 2016)